Chu Tours Hopital Bretonneau Service Pneumologie

Tours 37000

0 studies enrolling now · 4 studies all time

What they study most

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, NSCLC, Non-small Cell Lung Cancer, Refractory Mantle Cell Lymphoma (MCL), Relapsed Mantle Cell Lymphoma, Small Lymphocytic Lymphoma

Studies at this site

• A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer — Stopped early
• A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL — Running, not enrolling
• Study of BGB-11417 Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma — Running, not enrolling
• A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia — Completed